DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» CM156
CM156
The Cross-Talk of HIV-1 Tat and Methamphetamine in HIV-Associated Neurocognitive Disorders
(19) United States (12) Patent Application Publication (10) Pub
Lobelane Analogs with Various Methylene Linker Lengths and Acyclic Lobelane Analogs As Potential Pharmacotherapies to Treat Methamphetamine Abuse
A Role for Sigma Receptors in Stimulant Self-Administration and Addiction Jonathan L
The Involvement of Sigma Receptor Modulation in the Antidepressant Effects of Ketamine and the Neurotoxic Actions of Methamphetamine
September, 2010
2009 Program
CM156, a Sigma Receptor Ligand, Reverses Cocaine-Induced Place Conditioning and Transcriptional Responses in the Brain
Meeting Program
BBC Program V6 Reduced
Metabolic Stability and Pharmacokinetics in Lead Optimization of Potential Anti-Psychostimulant Pharmacotherapies
NIH Public Access Author Manuscript Expert Opin Ther Targets
(1) 13350 CPDD 09.Frontmatter2-Pg1-2
Evaluation of Novel Sigma Receptor Antagonists Against METH- Induced Neurotoxicity: in Vivo and in Vitro Studies
Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine
The Evaluation of Az66, a Highly Selective Sigma-1 and Sigma-2 Receptor Antagonist, for Its Anticonvulsive Effects in C57bl/6 M
Sex Steroids and Gene Variants in Bipolar Disorder
HHS Public Access Author Manuscript
Top View
Behavioural Pharmacology of Novel Kappa Opioid Compounds
Pharmacokinetic Evaluation of a Novel Compound, Sn79, a Putative Sigma-2 Receptor Antagonist, by Intravenous and Oral Administration in Rats